Skip to content

A phase II randomized controlled trial on effect of digestive enzymes for the development of nonalcoholic fatty liver disease (NAFLD) after pancreaticoduodenectomy.

A phase II randomized controlled trial on effect of digestive enzymes for the development of nonalcoholic fatty liver disease (NAFLD) after pancreaticoduodenectomy. - A phase II randomized controlled trial on effect of digestive enzymes for the development of nonalcoholic fatty liver disease (NAFLD) after pancreaticoduodenectomy.

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000017266
Enrollment
100
Registered
2015-04-24
Start date
2015-04-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who need pancreaticoduodenectomy

Interventions

Control group: Oral administration of conventional digestive enzyme (common dosage) after pancreraticoduodenectomy Test group: Oral administration of high potent digestive enzyme (common dosage) after

Sponsors

National Defense Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Planned to undergo pancreaticoduodenectomy R0 or R1 operation Sufficient oral intake at one month after surgery Adequate organ function Written informed consent

Exclusion criteria

Exclusion criteria: Preoperative fatty liver Positive HBs antigen or HCV antibody alcohol abuse total pancreatectomy R2 operation Gastrointestinal disease with malabsorption Other reason that attending doctors consider

Design outcomes

Primary

MeasureTime frame
The incidence of non alcoholic fatty liver disease one year after surgery

Secondary

MeasureTime frame
The nutritional status, pancreatic endocrine and exocrine function one year after surgery

Countries

Japan

Contacts

Public ContactMakoto Nishikawa

National Defense Medical College Department of Surgery

nishikawa@ndmc.ac.jp042-995-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026